Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drew Weissman

Showing results (91-100 of 293) with videos related to

Pageof 30
Sort By:
Nature Communications|May 11, 2021
Author Correction: Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNAFatima Rizvi, Elissa Everton, Anna R Smith, et al.
Carcinogenesis|November 13, 2025
SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancerShinji Nakamichi, Natalia von Muhlinen, Leo Yamada, et al.
NPJ Vaccines|December 26, 2025
An influenza HA mRNA-LNP vaccine induces potent responses in newborn nonhuman primates that enhance protection from challengeCourtney L Page, Beth C Holbrook, Kali F Crofts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2015
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory SyndromeShruthi Ravimohan, Neo Tamuhla, Kebatshabile Nfanyana, et al.
Nature Communications|January 17, 2023
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosisXuexiang Han, Ningqiang Gong, Lulu Xue, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosisJilian R Melamed, Jenna Muscat-Rivera, Michael Kegel, et al.
Journal of Bacteriology|September 25, 2012
Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosisGregory P Bisson, Carolina Mehaffy, Corey Broeckling, et al.
The Lancet. Infectious Diseases|February 13, 2015
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort studyShruthi Ravimohan, Neo Tamuhla, Andrew P Steenhoff, et al.
British Journal of Clinical Pharmacology|October 30, 2016
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activationChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
Lipid Nanoparticle Composition Drives mRNA Delivery to the PlacentaRachel E Young, Katherine M Nelson, Samuel I Hofbauer, et al.
Pageof 30

Showing results (91-100 of 293) with videos related to

Sort By:
Pageof 30
Nature Communications|May 11, 2021
Author Correction: Murine liver repair via transient activation of regenerative pathways in hepatocytes using lipid nanoparticle-complexed nucleoside-modified mRNAFatima Rizvi, Elissa Everton, Anna R Smith, et al.
Carcinogenesis|November 13, 2025
SRSF3 knockdown-induced cellular senescence as a possible therapeutic strategy for non-small cell lung cancerShinji Nakamichi, Natalia von Muhlinen, Leo Yamada, et al.
NPJ Vaccines|December 26, 2025
An influenza HA mRNA-LNP vaccine induces potent responses in newborn nonhuman primates that enhance protection from challengeCourtney L Page, Beth C Holbrook, Kali F Crofts, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2015
Robust Reconstitution of Tuberculosis-Specific Polyfunctional CD4+ T-Cell Responses and Rising Systemic Interleukin 6 in Paradoxical Tuberculosis-Associated Immune Reconstitution Inflammatory SyndromeShruthi Ravimohan, Neo Tamuhla, Kebatshabile Nfanyana, et al.
Nature Communications|January 17, 2023
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosisXuexiang Han, Ningqiang Gong, Lulu Xue, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Anionic lipids modulate mRNA-lipid nanoparticle immunogenicity and confer protection in a mouse model of multiple sclerosisJilian R Melamed, Jenna Muscat-Rivera, Michael Kegel, et al.
Journal of Bacteriology|September 25, 2012
Upregulation of the phthiocerol dimycocerosate biosynthetic pathway by rifampin-resistant, rpoB mutant Mycobacterium tuberculosisGregory P Bisson, Carolina Mehaffy, Corey Broeckling, et al.
The Lancet. Infectious Diseases|February 13, 2015
Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort studyShruthi Ravimohan, Neo Tamuhla, Andrew P Steenhoff, et al.
British Journal of Clinical Pharmacology|October 30, 2016
Isoniazid clearance is impaired among human immunodeficiency virus/tuberculosis patients with high levels of immune activationChristopher Vinnard, Shruthi Ravimohan, Neo Tamuhla, et al.
Biorxiv : the Preprint Server for Biology|January 4, 2023
Lipid Nanoparticle Composition Drives mRNA Delivery to the PlacentaRachel E Young, Katherine M Nelson, Samuel I Hofbauer, et al.
Pageof 30